New Experimental Pill Daraxonrasib Shows Promise in Extending Survival for Advanced Pancreatic Cancer Patients
A new experimental drug, daraxonrasib, has shown promising results in extending survival for patients with advanced pancreatic cancer, potentially marking a significant advancement in treatment options for this challenging disease.